Dashboard
Manage Tickers

CMPSCOMPASS Pathways plc

Nasdaq compasspathways.com


$ 7.18 $ -0.07 (-0.97 %)    

Thursday, 06-Jun-2024 10:34:37 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 463.77 $ 0.10 (0.02 %)
DIA $ 389.00 $ 0.29 (0.07 %)
SPY $ 534.77 $ -0.20 (-0.04 %)
TLT $ 92.99 $ 0.11 (0.12 %)
GLD $ 218.62 $ 0.78 (0.36 %)
$ 7.47
$ 7.25
$ 6.98 x 100
$ 7.19 x 200
$ 7.03 - $ 7.25
$ 5.01 - $ 12.75
2,585,090
na
479.74M
$ 1.57
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-lands-end-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Lands' End Shares Are Trading Lower? H...
06/05/2024 17:04:26

whats-going-on-with-mindmed-and-psychedelic-stocks
What's Going On With MindMed And Psychedel...
06/05/2024 14:58:55

Mind Medicine (MindMed) shares are trading lower Wednesday after a Food and Drug Administration (FDA) panel rejected the approv...

douyu-international-posts-q1-results-joins-annexon-dollar-tree-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
DouYu International Posts Q1 Results, Join...
06/05/2024 12:07:39

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
06/05/2024 12:06:43

why-stitch-fix-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket
Why Stitch Fix Shares Are Trading Higher B...
06/05/2024 09:27:25

gsk-boston-beer-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
GSK, Boston Beer And Other Big Stocks Movi...
06/03/2024 12:13:57

Core News & Articles
'Top Federal Drug Official Says There's 'T...
05/24/2024 15:47:04

https://www.marijuanamoment.net/top-federal-drug-official-says-theres-tremendous-excitement-around-psych

hc-wainwright--co-reiterates-buy-on-compass-pathways-maintains-120-price-target
HC Wainwright & Co. Reiterates Buy on Comp...
05/13/2024 09:45:59

HC Wainwright & Co. analyst Patrick Trucchio reiterates Compass Pathways (NASDAQ:CMPS) with a Buy and maintains $120 pri...

pot-company-gets-license-to-open-psilocybin-service-center-the-sacred-mushroom-in-oregon
Pot Company Gets License To Open Psilocybi...
05/09/2024 13:29:42

compass-pathways-reports-q1-cash-and-cash-equivalents-of-2629m
Compass Pathways Reports Q1 Cash And Cash ...
05/08/2024 10:54:44

Second quarter 2024 net cash used in operating activities is expected to be in the range of $32 million to $38 million. The ...

compass-pathways-q1-2024-gaap-eps-055-misses-048-estimate
Compass Pathways Q1 2024 GAAP EPS $(0.55) ...
05/08/2024 10:52:59

compass-pathways-announced-topline-results-from-an-open-label-phase-2-study-of-comp360-psilocybin-treatment-for-post-traumatic-stress-disorder-the-study-met-its-primary-safety-endpoint-and-available-secondary-efficacy-endpoints
Compass Pathways Announced Topline Results...
05/08/2024 10:41:00

Study met primary safety endpoint; administration was well tolerated, with no serious adverse events observed Early and clin...

Core News & Articles
"FDA Expert Committee Will Review MDMA-Ass...
05/07/2024 15:54:11

https://www.marijuanamoment.net/fda-expert-committee-will-review-mdma-assisted-therapy-for-ptsd-next-month/The Food and Drug Ad...

compass-pathways-mindful-health-solutions-enter-research-collaboration-agreement-to-inform-development-of--scalable-and-cost-effective-delivery-model-for-comp360-psilocybin-treatment
Compass Pathways, Mindful Health Solutions...
05/02/2024 10:44:10

This is the latest of several collaborations for Compass, intended to better understand a range of potential approaches to deli...

cantor-fitzgerald-reiterates-overweight-on-compass-pathways
Cantor Fitzgerald Reiterates Overweight on...
04/30/2024 14:16:35

Cantor Fitzgerald analyst Charles Duncan reiterates Compass Pathways (NASDAQ:CMPS) with a Overweight.

compass-pathways-and-journey-clinical-have-collaborated-to-inform-development-of-scalable-and-practical-delivery-and-healthcare-provider-training-model-for-comp360-psilocybin-treatment-if-approved-for-treatment-resistant-depression
Compass Pathways And Journey Clinical Have...
04/29/2024 10:38:05

cantor-fitzgerald-reiterates-overweight-on-compass-pathways
Cantor Fitzgerald Reiterates Overweight on...
04/19/2024 14:40:52

Cantor Fitzgerald analyst Charles Duncan reiterates Compass Pathways (NASDAQ:CMPS) with a Overweight.

cantor-fitzgerald-reiterates-overweight-on-compass-pathways
Cantor Fitzgerald Reiterates Overweight on...
04/18/2024 14:05:17

Cantor Fitzgerald analyst Charles Duncan reiterates Compass Pathways (NASDAQ:CMPS) with a Overweight.

psyched-dea-revisits-ban-on-two-psychedelics-farewell-russell-newcombe-podcast-episode-on-kanna--more
Psyched: DEA Revisits Ban On Two Psychedel...
04/17/2024 12:42:33

whos-who-in-cannabis-latest-executive-changes-you-should-know-about
Who's Who In Cannabis: Latest Executive Ch...
04/16/2024 00:22:56

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION